Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?

Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.6061/CLINICS/2018/E361
P932PMC publication ID6201148
P698PubMed publication ID30379223

P2093author name stringMarisa Dolhnikoff
Sheila Aparecida Coelho Siqueira
Fabiola Del Carlo Bernardi
Teresa Takagaki
Marcela Del Carlo Bernardi
P2860cites workPhase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancerQ29620301
United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among femalesQ38506876
The impact of immunohistochemistry on the classification of lung tumors.Q38822314
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lungQ44398817
p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) categoryQ47136556
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.Q51334457
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.Q51563657
Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.Q51630971
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.Q52844020
Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells.Q52914937
Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.Q53582166
Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.Q54446617
ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material ApproachQ56779202
Targeted therapy for lung cancerQ84895468
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomasQ87125545
P407language of work or nameEnglishQ1860
P921main subjectimmunohistochemistryQ899285
P304page(s)e361
P577publication date2018-10-29
P1433published inClinicsQ26841864
P1476titleLung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
P478volume73

Search more.